|
Q |
Arrd3 |
Age-related retinal degeneration QTL 3 |
|
IDA |
|
RGD |
PMID:22300709 |
RGD:7794750 |
NCBI chr 1:183,970,203...243,914,901
|
|
|
Q |
Vie1 |
Viral induced encephalitis QTL 1 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
Q |
Vie2 |
Viral induced encephalitis QTL 2 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 3:145,956,084...169,034,231
|
|
Q |
Vie3 |
Viral induced encephalitis QTL 3 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 6:96,833,997...140,994,061
|
|
Q |
Vie4 |
Viral induced encephalitis QTL 4 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:62,933,508...82,490,359
|
|
Q |
Vie5 |
Viral induced encephalitis QTL 5 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
|
Q |
Eae12 |
Experimental allergic encephalomyelitis QTL 12 |
|
IDA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr10:92,238,497...101,012,337
|
|
Q |
Eae13 |
Experimental allergic encephalomyelitis QTL 13 |
|
IDA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr12:24,139,202...36,638,073
|
|
Q |
Eae14 |
Experimental allergic encephalomyelitis QTL 14 |
|
IDA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr13:23,203,448...68,203,448
|
|
Q |
Eae15 |
Experimental allergic encephalomyelitis QTL 15 |
|
IDA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr18:76,477,814...77,209,844
|
|
Q |
Eae16 |
Experimental allergic encephalomyelitis QTL 16 |
|
IDA |
|
RGD |
PMID:12517974 |
RGD:629629 |
NCBI chr 8:8,462,195...110,921,472
|
|
Q |
Eae17 |
Experimental allergic encephalomyelitis QTL 17 |
|
IDA |
|
RGD |
PMID:12517974 |
RGD:629629 |
NCBI chr13:8,897,350...101,631,289
|
|
Q |
Eae2 |
Experimental allergic encephalomyelitis QTL 2 |
|
IDA |
|
RGD |
PMID:9973459 |
RGD:69694 |
NCBI chr 4:21,333,343...39,505,420
|
|
Q |
Eae3 |
Experimental allergic encephalomyelitis QTL 3 |
|
IDA |
|
RGD |
PMID:9973459 |
RGD:69694 |
NCBI chr10:26,521,957...61,345,413
|
|
Q |
Eae4 |
Experimental allergic encephalomyelitis QTL 4 |
|
IDA |
|
RGD |
PMID:10072499 |
RGD:69712 |
NCBI chr 9:1...25,661,317
|
|
|
Q |
Mcs31 |
Mammary carcinoma susceptibility QTL 31 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:77,813,894...111,552,878
|
|
Q |
Mcs32 |
Mammary carcinoma susceptibility QTL 32 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 1:115,540,693...238,914,717
|
|
Q |
Mcs33 |
Mammary carcinoma susceptibility QTL 33 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:131,345,754...166,875,058
|
|
Q |
Mcs34 |
Mammary carcinoma susceptibility QTL 34 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|
|
Q |
Strs4 |
Sensitivity to stroke QTL 4 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr 1:78,430,536...123,430,536
|
|
Q |
Strs5 |
Sensitivity to stroke QTL 5 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr18:49,999,958...65,845,095
|
|
Q |
Strs6 |
Sensitivity to stroke QTL 6 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr 5:134,972,980...138,113,556
|
|
Q |
Strs7 |
Sensitivity to stroke QTL 7 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr15:40,289,901...49,308,583
|
|
|
Q |
Iddm15 |
Insulin dependent diabetes mellitus QTL 15 |
|
IDA |
|
RGD |
PMID:11327715 |
RGD:619685 |
NCBI chr18:60,622,311...77,209,844
|
|
Q |
Iddm18 |
Insulin dependent diabetes mellitus QTL 18 |
|
IDA |
|
RGD |
PMID:11327715 |
RGD:619685 |
NCBI chr 6:116,506,292...130,245,370
|
|
Q |
Iddm20 |
Insulin dependent diabetes mellitus QTL 20 |
|
IDA |
|
RGD |
PMID:15793267 |
RGD:1358924 |
NCBI chr17:13,986,773...21,975,515
|
|
|
Q |
Edcs1 |
Endometrial carcinoma susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr11:18,976,208...24,697,116
|
|
Q |
Edcs2 |
Endometrial carcinoma susceptibility QTL2 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr12:6,833,190...17,870,186
|
|
Q |
Edcs3 |
Endometrial carcinoma susceptibility QTL3 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr20:1...25,159,026
|
|
Q |
Edcs4 |
Endometrial carcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr 1:206,081,677...251,081,677
|
|
Q |
Edcs5 |
Endometrial carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr17:57,246,723...70,852,846
|
|
|
Q |
Eae20 |
Experimental allergic encephalomyelitis QTL 20 |
|
IDA |
|
RGD |
PMID:15634914 |
RGD:1547849 |
NCBI chr 4:153,031,106...158,841,762
|
|
Q |
Eae24 |
Experimental allergic encephalomyelitis QTL 24 |
|
IDA |
|
RGD |
PMID:19675581 |
RGD:2317591 |
NCBI chr 4:66,993,185...72,752,834
|
|
Q |
Eae25 |
Experimental allergic encephalomyelitis QTL 25 |
|
IDA |
|
RGD |
PMID:19675581 |
RGD:2317591 |
NCBI chr 4:78,882,817...83,007,655
|
|
Q |
Eae27 |
Experimental allergic encephalomyelitis QTL 27 |
|
IDA |
|
RGD |
PMID:19675581 |
RGD:2317591 |
NCBI chr 4:103,194,805...112,478,794
|
|
Q |
Eae8 |
Experimental allergic encephalomyelitis QTL 8 |
|
IDA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr19:24,816,041...33,061,905
|
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:43,827,364...169,034,231
|
|
|
Q |
Eae10 |
Experimental allergic encephalomyelitis QTL 10 |
|
IDA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr14:17,622,685...18,274,498
|
|
Q |
Eae5 |
Experimental allergic encephalomyelitis QTL 5 |
|
IDA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr12:19,610,870...46,669,029
|
|
|
Q |
Arrd1 |
Age-related retinal degeneration QTL 1 |
|
IDA |
|
RGD |
PMID:22300709 |
RGD:7794750 |
NCBI chr 1:100,357,752...183,970,443
|
|
Q |
Arrd2 |
Age-related retinal degeneration QTL 2 |
|
IDA |
|
RGD |
PMID:22300709 |
RGD:7794750 |
NCBI chr 1:183,970,203...243,914,901
|
|
|
Q |
Tls2 |
T-lymphoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:80,221,299...109,401,111
|
|
Q |
Tls3 |
T-lymphoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:51,774,612...95,600,334
|
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:1,041,931...66,113,562
|
|
|
Q |
Schws1 |
Schwannoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:40,035,094...102,359,817
|
|
Q |
Schws2 |
Schwannoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
|
|
Q |
Schws3 |
Schwannoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 3:118,839,124...163,839,124
|
|
Q |
Schws4 |
Schwannoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 6:83,190,345...106,747,639
|
|
Q |
Schws7 |
Schwannoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:4,765,527...19,816,042
|
|
Q |
Schws8 |
Schwannoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:94,968,928...139,968,928
|
|
Q |
Schws9 |
Schwannoma susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:61,747,639...106,747,639
|
|
|
Q |
Renag1 |
Renal agenesis QTL 1 |
|
IDA |
|
RGD |
PMID:16845468 |
RGD:1580355 |
NCBI chr14:8,170,668...68,298,175
|
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:15,114,598...34,521,833
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:4,606,607...17,617,956
|
|
|
Q |
Panci1 |
Pancreas inflammation QTL 1 |
|
IDA |
|
RGD |
PMID:11414764 |
RGD:619682 |
NCBI chr 7:116,677,189...127,103,496
|
|
|
Q |
Toxo1 |
Toxoplasma gondii resistance QTL 1 |
|
IDA |
|
RGD |
PMID:16407112 |
RGD:1578521 |
NCBI chr10:52,200,030...59,378,278
|
|